Mepindolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00Q31ER368. European Medicines Agency schedules Mepindolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08750MIG. Mepindolol generally arises in the molecular formula C15H22N2O2. The term MEPINDOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, no10, 1977, list 17.) MEPINDOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mepindolol under HS 29339990 and SITC 51577. As of Q4 2014, MEPINDOLOL remains the US FDA Preferred Term for this commodity. Mepindolol bears US NLM identifiers UMLS ID C0065961 and NCI Concept Code C84659. SMILES: O(CC(O)CNC(C)C)C1C2C([NH]C(C2)C)CCC1.